US 6,335,333 B1 · N-arylsulfonylamino acid omega-amides

Abstract

Compounds of the formula I: stereoisomeric forms, and physiologically tolerable salts thereof are suitable for the production of pharmaceuticals for the therapy and prophylaxis of disorders involving matrix-degrading metalloproteinases.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/749,034Filed 28 Dec 2000

Granted

1 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification16 codes

C07D 209/08
Indoles; Hydrogenated indoles: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms…
A61P 1/02
Drugs for disorders of the alimentary tract or the digestive system: stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
A61P 9/10
Drugs for disorders of the cardiovascular system: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary…
A61P 9/14
Drugs for disorders of the cardiovascular system: vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

N-arylsulfonylamino acid omega-amides

Life of this patent

Abstract

Claims0

N-arylsulfonylamino acid omega-amides

Life of this patent

Abstract

Claims0